Pharma

Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin.

In 2016, we rounded up pharma news in the first, second, and third quarter of the year.

Mountain View, California-based Glooko is collaborating with Danish pharmaceutical company Novo Nordisk to develop a digital diabetes management platform.

Cambridge-based MC10, which makes paper-thin adhesive health sensors, and Belgium-based pharma company UCB have completed the Parkinson's study they began in 2014 and are aiming to publish the results later this year, the two companies announced.

According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology.

There are many approaches to using digital technology to promote medication adherence, from tiny sensors embedded in pills to Bluetooth-connected pill boxes, to simple reminder apps.

Novartis has announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler, for people who have COPD.

Foster City-based Oration has launched its mobile offering that helps employees save money on prescriptions.

One of the biggest ways the changing digital health landscape will affect the pharma industry is that pharma companies increasingly stand to lose control over their own stories, according to a new report from McKinsey & Company, who spoke to 20 thought leaders in various pharma-adjacent sectors.

Google Life Sciences has finally gotten its new name as an independent company under the aegis of Alphabet: Verily.